COMMUNIQUÉS West-GlobeNewswire

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)
22/03/2019
FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin) PARIS and THE WOODLANDS, TX - March 22, 2019 - The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New [...]
Sanofi : La FDA publie une lettre de réponse complète au sujet de Zynquista(TM) (sotagliflozine)
22/03/2019
La FDA publie une lettre de réponse complète au sujet de Zynquista(TM) (sotagliflozine) Paris et The Woodlands (Texas) - Le 22 mars 2019 - La Food and Drug Administration (FDA) des États-Unis a publié une lettre de [...]
Lexicon Pharmaceuticals to Host Conference Call and Webcast Today, March 22, 2019 to Provide a Regulatory Update on Sotagliflozin in Type 1 Diabetes
22/03/2019
THE WOODLANDS, Texas, March 22, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that management will conduct a conference call and live webcast today, Friday, March 22, 2019, at 2: [...]
FDA Issues Complete Response Letter for Zynquista™ (sotagliflozin)
22/03/2019
PARIS and THE WOODLANDS, Texas, March 22, 2019 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application for investigational Zynquista™ ( [...]
IBA SA: transparency notification
22/03/2019
IBA – TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, March 22, 2019, 17.35 - IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it [...]
IBA SA - Notification de transparence
22/03/2019
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 22 mars 2019, 17.35 – IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
Correction: Removal of the MAR plate in the release: The observation status of Oncology Venture is removed
22/03/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that the observation status for the share on Nasdaq First North has been removed. The decision was taken by [...]
2018 Annual Report and Accounts and Notice of AGM
22/03/2019
LONDON, March 22, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Correction to Financial Statement Bulletin of BBS-Bioactive Bone Substitutes Plc, published 22th March 2019 at 9:00 CET
22/03/2019
BBS-Bioactive Bone Substitutes Plc Correction to Financial Statement Bulletin of BBS-Bioactive Bone Substitutes Plc, published 22th March 2019 at 9:00 CET. Unfortunately, some incorrect dates and periods were in the [...]
Assure Holdings Announces Estimated Impact from Fourth Quarter 2018 Increase in Bad Debt Expense
22/03/2019
DENVER, March 22, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced today that it was increasing [...]
The observation status of Oncology Venture is removed
22/03/2019
Press release Hørsholm, Denmark and Cambridge, MA, US, March 22, 2019 – Oncology Venture A/S announced today that the observation status for the share on Nasdaq First North has been removed. The decision was taken by [...]
Providence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular Biology
22/03/2019
NORCROSS, Ga., March 22, 2019 (GLOBE NEWSWIRE) -- Providence Cancer Institute and Galectin Therapeutics Inc. (NASDAQ: GALT) , the leading developer of therapeutics that target galectin proteins, announced today a [...]
resTORbio, Inc. Announces Closing Public Offering of Common Stock
22/03/2019
BOSTON, March 22, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (“resTORbio” or the “Company”) (Nasdaq:TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to [...]
Coherus BioSciences Announces New Employment Inducement Grants
22/03/2019
REDWOOD CITY, Calif., March 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective March 21, 2019, the compensation committee of the company’s board of directors granted [...]
Better Choice Company Appoints Four New Board of Director Members
22/03/2019
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc (OTCQB: BTTR) (OTCQB: BTTRD) (the “Company”) today announced the appointment of Lori Taylor, Damian Dalla-Longa, Jeff Davis and Michael Galego to [...]
SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update
22/03/2019
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Wildflower Brands Featured in CannabisNewsWire Publication Discussing the Farm Bill’s Positive Effect on CBD Sales
22/03/2019
NEW YORK, March 22, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted [...]
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019
22/03/2019
NEW YORK , March 22, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]
Sun BioPharma Provides Business Update and Files Annual Report for 2018
22/03/2019
Front-Line Combination Study with Gemcitabine and Nab-Paclitaxel enrolling second Cohort of Phase 1a Company reinstates founder and Executive Chairman, Dr. Michael Cullen as President and Chief Executive Officer, [...]

Pages